Streetbeat News

Price Targets

IQV

Citigroup analyst Patrick Donnelly has maintained a Neutral rating on IQVIA Holdings (NYSE:IQV) and increased the price target from $190 to $225.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 12:08 pm

HUN

Morgan Stanley analyst Angel Castillo downgraded Huntsman Corporation (NYSE:HUN) from Overweight to Equal-Weight and set a price target of $28.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 12:07 pm

ICLR

Citigroup analyst Patrick Donnelly has reaffirmed a Buy rating on Icon (NASDAQ:ICLR) and increased the price target from $300 to $315.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 12:06 pm

GLPI

Mizuho analyst Haendel St. Juste has downgraded Gaming and Leisure Properties (GLPI) from Buy to Neutral and reduced the price target from $50 to $47.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 12:05 pm

DHR

Citigroup analyst Patrick Donnelly has reaffirmed a Buy rating on Danaher Corporation (NYSE:DHR) and increased the price target from $240 to $255.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 12:05 pm

CRL

Citigroup analyst Patrick Donnelly has maintained a Neutral rating on Charles River (NYSE:CRL) and increased the price target from $190 to $215.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 12:03 pm

PH

Parker Hannifin (NYSE:PH) received 5 bullish analyst ratings in the last quarter with no bearish or neutral ratings. The average price target is $484.2, representing an upside from the current price of $438.63. This target has increased by 7.96% from the previous target of $448.50. Analysts typically review stocks quarterly or after major company updates, considering financials, meetings, and insider information.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 12:00 pm

EOG

EOG Resources (NYSE:EOG) received 16 analyst ratings in the last quarter, with an average 12-month price target of $150.56, representing a 0.77% decrease from the previous target of $151.73. Ratings were predominantly bullish or somewhat bullish, with no bearish sentiments. Analysts base their ratings on financial predictions and company performance metrics.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 12:00 pm

BPMC

Blueprint Medicines (NASDAQ:BPMC) received a mix of analyst ratings in the last quarter, with 2 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average 12-month price target from 5 analysts is $73.00, with a high of $85.00 and a low of $58.00. This target is a 28.07% increase from the previous target of $57.00. Analyst ratings are based on information from company events, financial statements, and insider conversations, and they provide guidance on stock performance.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 12:00 pm

EQR

Equity Residential (NYSE:EQR) received 7 analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, and 5 indifferent. The average 12-month price target is $60.5, representing a 9.02% decrease from the previous target of $66.50. Analysts provide these ratings based on financial analysis and company insights.

Portfolio Pulse from Benzinga Insights

December 11, 2023 | 12:00 pm